Meeting
2011 ASCO Annual Meeting
Evaluation of low-dose CT scans for surveillance in stage I testicular cancer.
Authors
P. W. M. Chung
Department of Radiation Oncology, Princess Margaret Hospital and University of Toronto, Toronto, ON, Canada
P. W. M. Chung , M. O'Malley , M. A. S. Jewett , T. Panzarella , D. Hogg , M. J. Moore , P. Bedard , L. Anson-Cartwright , B. Tew-George , M. A. Haider , M. K. Gospodarowicz , P. R. Warde
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer
Sub Track
Germ Cell/Testicular
Citation
J Clin Oncol 29: 2011 (suppl; abstr 4565)
Abstract #
4565
Poster Bd #
20
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Stage I testicular cancer: Five-year follow-up rates and reasons for non-adherence.
First Author: Tim Karmas
Poster
2020 Genitourinary Cancers Symposium
WATChmAN: A randomized trial of virtual surveillance versus standard in-person care for clinical stage I testicular cancer.
First Author: Robert James Hamilton
Poster
2016 Genitourinary Cancers Symposium
Optimization of an imaging protocol for stage I seminoma surveillance based on variations in relapse location over time.
First Author: Andrew McPartlin
Poster
2024 ASCO Genitourinary Cancers Symposium
Association of DAZL expression with risk of recurrence in clinical stage 1 testicular germ cell tumors.
First Author: Alok Tewari